Clinical Trial Update: Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP Trial [Phase 3]

View source ↗

Summary

Phase 3 STAMP trial evaluating pembrolizumab versus observation after surgery for pathologic stage I–III cutaneous Merkel cell carcinoma; the study is active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Merkel Cell Carcinoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8 | Phase 3 | Status: ACTIVE_NOT_RECRUITING